Yes, we plan to vaccinnate, but...

Why is it that all the authors of these vaccine studies suddenly end up working for the vaccine companies? It's just a question.

From the NY Times
April 9, 2008, 5:03 pm
Is Mumps Making a Comeback?


An alarming outbreak of the mumps two years ago has raised questions about whether an additional vaccination is needed.

A report in The New England Journal of Medicine tracks the 2006 epidemic, the largest mumps outbreak in two decades in the United States. It occurred despite a national vaccination program aimed at eliminating the disease here by 2010.

Mumps is a viral infection characterized by fever and swollen salivary glands. Mumps had virtually disappeared in the United States in the 1990s, when doctors began using a second dose of measles-mumps-rubella vaccine among schoolchildren.

But surprisingly, most of those who became infected with mumps in the 2006 outbreak were college students who had received two doses of the vaccine. The outbreak raises questions about waning immunity and whether a third dose of vaccine may be needed.
The outbreak appeared to start in January 2006 on college campuses in Iowa.

By February, mumps was reported on other campuses, and by April the outbreak peaked, with 40 states reporting 2,786 cases. By the end of the year, a total of 6,584 cases and 85 hospitalizations had been reported, but no deaths occurred. Eight states — Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, South Dakota and Wisconsin — had the highest number of mumps cases.

The researchers noted that the virus likely came from students or other travelers from Britain, where there was a larger outbreak of the same strain. Since 43 percent of the world’s nations do not vaccinate against mumps, additional cases from overseas are likely, the report said.

At the time of the study, lead author Dr. Gustavo H. Dayan was employed by the Centers for Disease Control and Prevention. He now works for Sanofi Pasteur, which makes a mumps vaccine. In the United States, the mumps vaccine is sold by Merck.